Nothing Special   »   [go: up one dir, main page]

DE1491218A1 - Highly porous collagen tissue blood vessel prosthesis and method for producing the same - Google Patents

Highly porous collagen tissue blood vessel prosthesis and method for producing the same

Info

Publication number
DE1491218A1
DE1491218A1 DE19631491218 DE1491218A DE1491218A1 DE 1491218 A1 DE1491218 A1 DE 1491218A1 DE 19631491218 DE19631491218 DE 19631491218 DE 1491218 A DE1491218 A DE 1491218A DE 1491218 A1 DE1491218 A1 DE 1491218A1
Authority
DE
Germany
Prior art keywords
tube
collagen
blood vessel
highly porous
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19631491218
Other languages
German (de)
Other versions
DE1491218B2 (en
DE1491218C3 (en
Inventor
Miloslav Adam
Krajicek Dr Milan
Chvapil Dr Milos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spofa Vereinigte Pharma Werke
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of DE1491218A1 publication Critical patent/DE1491218A1/en
Publication of DE1491218B2 publication Critical patent/DE1491218B2/en
Application granted granted Critical
Publication of DE1491218C3 publication Critical patent/DE1491218C3/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005Use of materials characterised by their function or physical properties
    • A61L33/0011Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/062Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/236Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Laminated Bodies (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Description

Patentanwalt Dipl.-Ing. A. SPRp ER Göttingen, Groner Str. 37Patent attorney Dipl.-Ing. A. SPRp ER Göttingen, Groner Str. 37 Fernruf 59923 · Postscheckkonto: KSIn 86838 · Bankkonto: Kreissparkasse GöHingen 5254Fernruf 59923 · Postal checking account: KSIn 86838 · Bank account: Kreissparkasse GöHingen 5254 Privat: KJeperweg 6 ■ Fernruf 59923 1 A 9 1 2 1 8Private: KJeperweg 6 ■ Telephone 59923 1 A 9 1 2 1 8

I -' - ' ; ι ; pötti.-igen, den 9,12.1963I - '-'; ι; pötti.-igen, 9.12.1963

Meine Akte» 9566 s/My files »9566 s /

' SPO?A, Sji3?u2fenf podniKu pro zdravotniGkoUjTyrobu, Praiia (0S3R)'SPO? A, Sji3? U2fenf podniKu pro zdravotniGkoUjTyrobu, Praiia (0S3R)

Hoohporöse Kollajjen-Gewebe-Blutsefassprotneae und Verfauron zur -rierotellung derselben.High-porous Kollajjen tissue blood-catching protneae and Verfauron to -rierotstellung the same.

Die Erfiadung betrifft eine hoohporöse Kolla^en-Gevvebe-Blut^efüssprot-iQse und, ein Verfahren zur herstellung derselben·The experience concerns a high porous collagen-Gevvebe-Blood-Feet-Prot-iQse and, a process for making the same

Wie bekannt werden in der klinischen Praxis der Blutgefässohirur^jie zuru Ersetzen von resezierten Blutgefaasen Prothesen, welche aus verschiedenen, physiologisch inerten Kunstfasergeweben (Teflon, Dacron usw.) hergestellt sind, verwendet» Die Wand-As is well known in clinical practice, the blood vessel surgeon ^ jie to replace resected blood vessels prostheses, which are made of different, physiologically inert synthetic fiber fabrics (Teflon, Dacron, etc.), used »The wall

porösität solcher Prothesen beträgt etwa 15oo-2ooo ml Hg "in. bei einem Druok von 12o mm Hg. Die Konstruktion von 31ut- ^eXässprothesen mit höherer V/andporöaität /5ooo - lo.ooo ml ii^O/om^/i.in./, welche gemäss Forsohungser^ebniiisen für das weitere Gcij-icksal des implantierten Blutgefänsersatzey von Grundl»euGutun{ä ist, wird durch Kombination einerj resorbierbaren Hatorials mit einer dünnen Gewebeprotlieoe gelöst. Das reöorbierbaro tutorial hat nämlich die Aufgabe,während des HeilprozesEies die llutung dui*cii die Maschen des Kunstfaser^ewebes zu verhindern. porosity of such prostheses is about 150-2000 ml Hg "in. at a pressure of 12o mm Hg. The construction of 31ut- ^ eXässprothesen with higher V / andporöaität / 5ooo - lo.ooo ml ii ^ O / om ^ / i.in. /, which according to Forsohungser ^ ebniiisen for the further The fate of the implanted blood vessel set from Grundl »euGutun {ä is solved by combining a resorbable hatorial with a thin tissue protlieoe. The re-absorbable The task of the tutorial is during the healing process the lutung dui * cii to prevent the meshes of the synthetic fiber ^ ewebes.

909814/0057 bad original909814/0057 bad original

-2- H91218-2- H91218

Als resorbierbares Material wurden bisiier folgende Stoffe benutz* Catgutfaser, gegebenenfalls mit Kunstfasern zusammengewirkt oder —gewebt, amorphe Gelatine, Kollagenfilm in Form einer Röhre zusammengenäht* Die experimentelle Erprobung solcher Prothese war im Wesentlichen erfolglos mit Rücksicht darauf, dass die Versuchstiere grösstenteils (über 5o#) ausgeblutet - · waren. Ein kompliziertes Herstellungsverfahren und die Unmöglichkeit der durchlaufenden Qualitätskontrolle bei der Serienproduktion stellen weitere Fachteilβ dieser Methode dar.The following substances have been used as absorbable material * Catgut fiber, possibly combined or woven with synthetic fibers, amorphous gelatin, collagen film in the form of a Tube sewn together * The experimental testing of such The prosthesis was essentially unsuccessful considering that the test animals mostly bled out (over 50 #) - was. A complicated manufacturing process and the impossibility of continuous quality control in series production represent a further part of this method.

Es ist durch die vorliegende Erfindung gelungen, die genannten Mangel duroh Konstruktion einer hochporösen Kollagen-Gewebe-Blut^efässprothese gemäss Erfindung und duroh ein Verfahren zur Herstellung derselben zu beseitigen«,The present invention succeeded in achieving the aforementioned Deficiency due to the construction of a highly porous collagen-tissue-blood vessel prosthesis according to the invention and by eliminating a process for the production of the same «,

Diese Prothese, bestehend aus einer Röhre, hergestellt aus einem nichtresorbierbaren, physiologisch inerten Kunstfasergewebe, mit einer WandporTteität über 2000 ml ll^O/ma. /Min. bei einem Druck von 12o mm Hgf kombiniert mit dinem resorbierbaren Stoff, wie Catgut, Gelatine oder Kollagen, kennzeichnet, sichüra Wesentlichen darin, dass die aus einem nicht resorbia?- baren, physiologisoh inerten Kunstfasergewebe hergestellte Röhre die äussere Sohioht der Blutgefässprothese und eine selbsttragende Röhre, hergestellt aus einer Kollagenmasse, derer Resorbierbarkeit duroh teilweise ohemisohe Härtung modifiziert ist, die innere gohioht bildet, wobei die innere Oberfläche der Kollagenröhre mit einem Antikoagulationsmittel präpariert ist.This prosthesis, consisting of a tube, made of a non-resorbable, physiologically inert synthetic fiber fabric, with a wall porosity of over 2000 ml . / Min. at a pressure of 12o mm Hg f combined with a resorbable substance such as catgut, gelatine or collagen, is characterized essentially by the fact that the tube made of a non-resorbable, physiologically inert synthetic fiber fabric is the outer surface of the blood vessel prosthesis and a self-supporting one Tube made of a collagen mass, the absorbability of which is modified by partially ohemisous hardening, forms the inner gohioht, the inner surface of the collagen tube being prepared with an anticoagulant.

BAD ORIGINAL 9098U/0057 BATH ORIGINAL 9098U / 0057

U91218-U91218-

Diese Blutgefässprotheae kennzeichnet sioh ferner darin, dass ·" ihre innere Sohiaht eine Röhre bildetf die hergestellt ist aus einer mit Muoopolysaoohariden und/oder Glyoerin und/oder mit einem oder mehreren Antibiotioa angereioherten Kollagenmasse, wobei diese Komponenten entweder einzeln oder in verschiedenen Kombinationen zugesetzt werden k'önnene This Blutgefässprotheae features SiOH further that · "their inner Sohiaht forms a conduit f which is fabricated from a with Muoopolysaoohariden and / or Glyoerin and / or with one or more Antibiotioa angereioherten collagen mass, where these components can either be added individually or in various combinations can e

Eine weitere Ausbildung der Erfindung besteht darin, dass sioh zwischen der äusseren Kunstfasergewebesohicht und der inneren, aus einer chemisch modifizierten Kollagenmasse hergestellten Schicht, eine Zwisohensohioht aus einer amorphen, nativen chemisch nicht modifizierten Kollagenmasse befindet·Another embodiment of the invention consists in that sioh between the outer synthetic fiber fabric layer and the inner, made of a chemically modified collagen mass, an intermediate layer made of an amorphous, native one chemically unmodified collagen mass is located

Bei der etfindungsgemässen Herstellung der hooliporösen Blutgefässprothesen kann man ZeB0 so verfahren, dass man 'zunäohst desintegrierte und homogenisierte Kollagenmasse, zubereitet durch alkalische Quellung des Rind-Leimgallertgewebes, gegebenenfalls vermischt mit Muoopolysaoohariden und/oder Glyoerin und/oder mit einem oder mehreren Antibiotioa, in Form einer Röhre gestaltet, die man nachher in feuohtem oder trockenem Zustand mit einer hoohporösen O-eweberöhre überzieht, worauf man die innere Fläohe der Kollagenröhre duroh Einwirkung eines Härtungsmittels ohemisoh modifiziert und nach Auswaschen des Härtungemittele mit einem Antikoagulationsmittel präpariert·In the production of the hooliporous blood vessel prostheses according to the invention, ZeB 0 can be done in such a way that initially disintegrated and homogenized collagen mass, prepared by alkaline swelling of the beef glue gelatinous tissue, optionally mixed with muoopolysaoohariden and / or glycerin and / or with one or more antibiotics In the form of a tube, which is then covered in a wet or dry state with a porous O-tissue tube, whereupon the inner surface of the collagen tube is modified ohemisoh by the action of a hardening agent and, after washing out the hardening agent, is prepared with an anticoagulant

Eine besonders feste Verbindung beider Röhren kann man daduroh erzielen, dass man die hoohporöse Geweberöhre an der Kollagen-A particularly firm connection between the two tubes can be achieved achieve that the high-porous tissue tube on the collagen

röhre mit Hilfe einer duroh Bespritzen oder Anstreichen aufgetragenen Zwischenschicht aus amorpher, nativer, chemisch nicht modifizierter Kollagenmasse fixiert.tube with the help of a duroh spray or paint applied Fixed intermediate layer of amorphous, native, chemically unmodified collagen mass.

Die auf vorstehendem Wege hergestelltehoohporöse Blutgefässprothese lässt sich ohne Gefahr einer unmittelbaren oder später auftretenden , !kangdauerndeu Blutung durch die Prothesenwand implantieren. Bei der klinischen Anwendung, sind weder besondere Massnahmen noch ein spezielles Arbeitsverfahren bei der Operation erforderlich. Aus den bisherigen analogischen Forschungsergebnissen auf diesem Gebiet geht hervor, dass die hohe Porösität des nicht resorbierbaren Bestandteiles der erfindungsgeinässen Prothesen wesentlich bessere Resultate bei der Blutgefässrekonstruktion gewährleistet als es mit dem bisher benutzten Ersatzmaterial möglich war· .The high-porous blood vessel prosthesis manufactured in the above way can be carried out through the wall of the prosthesis without the risk of immediate or later occurring permanent bleeding implant. In clinical use, neither special measures nor a special working procedure are required Surgery required. The previous analogical research results in this area show that the high porosity of the non-absorbable component of the invention Prostheses ensure significantly better results in blood vessel reconstruction than with the previously used one Replacement material was possible ·.

Das Anbringen der resorbierberen selbsttragenden Röhre im Inneren der Kunstfasergeweberöhre lässt die Maschen des Gewebes relativ frei, so dass rasches Durohwaohsen der umliegenden Blutgefässzellgewebe erfolgen kann, ohne dass vorherigerAbbau des resorbierbaren Bestandteiles notwendig wäre· Die blutge-The attachment of the absorbable self-supporting tube in the Inside the synthetic fiber fabric tube leaves the meshes of the fabric relatively free, so that the surrounding area can be swiftly expanded Blood vessel cell tissue can take place without prior degradation of the absorbable component would be necessary

• rinnungshemmende Wirksamkeit der inneren Oberfläche verhindert die Bildung von Thromben. Ein weiterer Vorteil liegt darin, dass man biologische Eigenschaften des Materials aur Herstellung von Blutgefässprothesen gemäes Erfindung dank grosser ohemieoher Reaktivität der Kollagenmasse je nach Bedarf neuen Forschung*- ergebnissen anpassen kann. Das ist besondere für das Einwachsen des niohi resorbierbaren Bestandteiles und für die !Neubildung• Prevents the inner surface from having an anti-coagulant effect the formation of thrombi. Another advantage is that it has biological properties of the material for its manufacture of blood vessel prostheses according to the invention thanks to great ohemieoher Collagen mass reactivity as required by new research * - can adjust results. This is special for waxing of the niohi absorbable component and for the new formation

9098U/00579098U / 0057

U91218U91218

der. Blutgefässwänd wichtig. Durch chemische Härtung der Kolla-"genröLre lüsst si'Oh auch ihre Eesorptionsdauer beeinflussen und standardisieren, so dass keine vorzeitige Resorption dieser Röhre erfolgen kann·the. Blood vessel walls are important. By chemical hardening of the collagen tubes lets si'Oh also influence their absorption duration and standardize so that no premature resorption of this tube can occur

Das naousteilende Beispiel soll die Erfindung näher erläuternf ohne sie zu. be so kränken. The naousteilende example will illustrate the invention f without it. be so offended.

Das folgende Beispiel beschreibt das Erfiudungsneseutliche an einer AuBfiüirüngsforin der Erfindung«The following example clearly describes the invention an execution form of the invention "

Kollagenmasse, zubereitet durch alkalische ^uellu g des Rind-XeiKigallertgev/ebes, wird desintegriert und gründlich homogenisiert ^z.'B.' 24 Stunden lang in einem Homogenisator) und dann 24- otuhden lang in einem Kühlschrank bei 0-4 0 sich seibot belasten« Diese, auf vorstehendem Wege behandelte KoI-lageiiKariije kann man sonon zur Erzeugung von resorbierbaren, selbsttragenden Röhren, welche als Bestandteil einer kombi-* nierten iioohporösen Blutgefässprothese dienen, verv/enden«Collagen mass, prepared by alkaline uellu g of beef XeiKigallertgev / ebes, is disintegrated and thoroughly homogenized ^ e.g. 'B.' In a homogenizer for 24 hours) and then for 24- otuhden in a refrigerator at 0-4 0 itself seibot burden «This KoI-lageiiKariije treated in the above way can sonon be used to produce absorbable, self-supporting tubes, which serve as a component of a combined iioohporous blood vessel prosthesis, are used "

i^ ^oI-l'a enaia'.se ',.ann man auch get:e ^Θΐ£«ηΓί Ils durch Vermis'j:.f:i tiit Iiucopolyn^cchariden, z.B^ vom Typuis dor tl;raluronsäure (0,5 - 3,0;i), mit Glycerin (0,5 - 5,055>)oder mit /-ntibiotioa, J4»B. mit Chlortetracyklin (1 - 5 g/100 g' Mause), Tieomyoin (0,5 - 5 g/10Q g Masse) oder Baoitracin (10«000 - 50.000 E. lic. c Tanse) anreioiiern. Die genannt· η Komponente η kann man entv/odor einzeln· oder in verncxiiedenen Kombinationen zusetzen.i ^ ^ oI-l'a enaia'.se ', .ann one also ge t: e ^ Θΐ £ «ηΓί Ils by Vermis'j: .f: i tiit Iiucopolyn ^ cchariden, eg ^ from Typuis dor tl; r aluronic acid (0.5 - 3.0; i), with glycerine (0.5 - 5.055>) or with / -ntibiotioa, J4 »B. enrich with chlortetracycline (1 - 5 g / 100 g of mouse), tieomyoin (0.5 - 5 g / 10% g mass) or baoitracin (10,000 - 50,000 E. lic. c Tanse). The component η mentioned can be added either individually or in cross-linked combinations.

Au» χ ν -'luf diene Vieiee aufgearbeiteten Kollageniaanse wirdAu "χ ν -'luf serve Vieiee reclaimed Kollageniaanse is

909914/0057 bad original909914/0057 bad original

H91218H91218

dann in einer iuit rotierendem Ziehkopf versehenen Presämaschine duroli Sußarai-;ii.'·: in":en und Verbindung einzelner Pas- rn eine Röhre mit gew: nscutiuu Dur comes, er (zoßo 9 nun) und Wandstärke ( z.B. 0,4- - 0,6 nun) -^ezojbn, und zv;?r unter gleichzeitigem Durchblasen von Luft, ZoBo unter 40 - 150-mm Wassersäuledruck. Die fertige Röhre trocknet man dann langst ia bei einer Temperatur von 15 25° O in mildem Luftstrom« Nach Trocknen überzieht man die Kollagenröhre mit Hilfe einer speziellen Vorrichtung mit der Kunstfasergeweberöhre, worauf man sie von innen mit einer l#-igen wässerigen 2, 4· , 6- Trimethoxytriazinlösung, nachher mit überschüssigem destilliertem Wasser und schliesslich mit einer Lösung eines geeigneten .Antikoagulationsmittels, z.B. mit einer Vi'o -igen wässrigen lieparinlösung durchwischto> Die herstellung der Blutgefassprotiiese beendigt man durch Trocknen unter bereits erwähnten Bedingungen« Durch Luftüberdruck in der inneren Röhre während de3 Trocknens wird eine feste Verbindung beicer Sohicxiten erzielt,, Diese Verbindung -kann man auch so verstärken, indem nisn zwischen beide Schichten eine dinne Zwischenschicht aus amorpher, natifyer, chemisch nicht modifizierter Follt'gen-1U..1 a.:e aufträgt „then provided in a iuit rotating pulling head Presämaschine duroli Sußarai-; ii '·. in ": s and connecting individual Pas-rn a tube with wt: nscutiuu major comes, he (z o ß o 9 now) and wall thickness (for example, 0 , 4- - 0.6 now) - ^ ezojbn, and zv;? R while blowing air through it, ZoBo under 40-150 mm water column pressure. The finished tube is then dried for a long time, generally at a temperature of 15-25 ° O in After drying, the collagen tube is covered with the synthetic fiber tube using a special device, whereupon it is covered from the inside with an aqueous 2, 4, 6-trimethoxytriazine solution, then with excess distilled water and finally with a solution of a .Antikoagulationsmittels suitable, for example, strength with a Vi'o aqueous lieparinlösung by wipes o> manufacturing of Blutgefassprotiiese to quit by drying under conditions already mentioned "by air pressure in the inner tube during drying, a de3 A firm connection between sohicxites is achieved, This connection can also be strengthened by applying a thin intermediate layer of amorphous, natural, chemically unmodified Follt'gen-1U..1 a .: e between the two layers.

Dio fertige Blutgefässprotuese wird dunn in eirtfhluftdiehten UmSOiLLa1Y, ζ.Γ.. in eine Glassampulle eingeschlossen und mit G-amma-Strahlung (z.B. in einer Gabe von 2<.1O r 5' Stunden 1 ng) sterilisiert.Dio is finished Blutgefässprotuese Dunn .. included in eirtfhluftdiehten UmSOiLLa 1 Y, ζ.Γ in a glass ampoule and G-amma-radiation sterilized (for example in a dose of 2 <.1O r 5 'hours 1 ng).

ORIGINALORIGINAL

9098U/00579098U / 0057

Claims (2)

Ρ A Ρ A Ly Hochporöse Kollagengevvebe-Blutgefässprothese,' bestehend aus einer Röhre, hergestellt aus einem nicht resorbierbaren, physiologisch inerten Kunstfasergewebe mit einer WandporÖsität über 2000 ml HpO/cm / Min. bei einem Druck von 120 ram Eg, kombiniert mit einem resorbierbaren Stoff, wie Catgut, Gelatine oder Kollagen, dadurch gekennzeichnet, dass die aus einem nicht ■ resox'bierbaren, physiologisch inerten Eunstfasergewebe hergestellte Röhre die äussere Schicht der Blutgefässprothese bildet und dass eine selbsttragende Röhre, hergestellt aus einer Kollagenmasse, deren Resorbierbarkeit durch teilweise chemiBche Härtung modifiziert ist, die innere Schicht bildet, vfobei die innere Oberfläche der Eollagenröhre mit einem Antikoagulationsmittel präpariert iste 'Ly Highly porous collagenous vascular prosthesis, 'consisting of a tube made of a non-absorbable, physiological inert synthetic fiber fabric with a wall porosity 2000 ml HpO / cm / min at a pressure of 120 ram Eg combined with an absorbable substance such as catgut, gelatine or collagen, characterized in that the non-■ Resox'bable, physiologically inert synthetic fiber fabric produced Tube forms the outer layer of the blood vessel prosthesis and that is a self-supporting tube made from a Collagen mass, whose absorbability is partly due to chemical Hardening is modified, which forms the inner layer, vfobei the inner surface of the egg tube with an anticoagulant is prepared ' 2. Hoohporöse Kollagen-Gewebe-Blutgefässprothese nach Anspruch 1, dadurch gekennzeichnet, dass die innere Schicht eine Rühre, hergestellt aus einer mit Muoopolysaoohariden und/oder Glycerin und/oder mit einem oder mehreren Antibiotioa angereicherten Kollagenmasse bildet, wobei diese Komponenten entweder einzeln oder i& verschiedenen Kombinationen zugesetzt werden können.2. High-porous collagen tissue blood vessel prosthesis according to claim 1, characterized in that the inner layer forms a tube made from a collagen mass enriched with muoopolysaooharides and / or glycerol and / or with one or more antibiotics, these components either individually or i & various combinations can be added. 5· Hochporöse Kollegen-Öewebe-Blutgefäesprothese naoh Aiispruoh 1, f oder 2, dadurch gekennaeiclineti dass sich üw ie often der äuseeren Eunstfösergewebesohloht und der inneren, aus ohemisoh modifi- 5 · Highly porous colleague tissue blood vessel prosthesis naoh Aiispruoh 1, f or 2, characterized by the fact that the outer esophageal tissue is ow often and the inner, ohemisoh modified 8 Ö 9 8 H / 0 0 5 7 bad original8 Ö 9 8 H / 0 0 5 7 bad original ziarter Kollagenmasse hergestellten Schicht, eine Zwischenschicht au* einet amorphen, nativen, chemisch nicht modifizierten Kollagenmasse, befindet« ,a layer made of delicate collagen mass, an intermediate layer made of amorphous, native, chemically unmodified collagen mass, " Verfahren zur Her*teilung voii Blutgefässprothdaen nach Anspruch 1 oder 2 oder 3,dadurch gekennzeichnet, dass man die zunächst desinWiirierte und homogenisierte Kollagenmäsee, zubereitet durch alkalische Quellung des Äind-leimgallertgewebest gegebenenfalls vermischt mit Muo©polysacchariden und/oder Glycerin und/oder mit einem oder mehreren /ntibiotica, in Form einer Röhre gesteiltet,-die man nachher in feuchtem oder trockaem Zustand mit einer hochporöäen Geweberöhre überzieht, worauf man die innere Oberfläche der Follagenröhre durch Einwirkung eines Härtungsmittels chemisch modifiziert und nach Auswaschen des Härtungsmittels mit einem Antikoagulationsmittel präparierteMethod for the production of blood vessel prostheses according to claim 1 or 2 or 3, characterized in that the first disinfected and homogenized collagen mills, prepared by alkaline swelling of the glue gelatinous tissue, if necessary mixed with muo © polysaccharides and / or glycerine and / or with one or more / ntibiotica, divided in the form of a tube, -die one afterwards in a wet or dry state with a The highly porous tube of tissue is coated, whereupon the inner surface of the follagen tube is covered by the action of a hardening agent chemically modified and prepared after washing out the hardener with an anticoagulant Verfahren nach Anspruch 4, dadurch gekennzeichnet, dass man die hochporöse Gevveberöhre an der iCollagenröhre mit,Hilfe einer durch Bespritzen oder Anstreichen aufgetragenen Zwischenschicht aus amorpher, nativer, chemisch nicht modifizierter-Kollagenmasse fixiert.Method according to claim 4, characterized in that the highly porous Gevveberöhre on the iCollagenröhre with the help of a Spraying or painting applied intermediate layer of amorphous, native, chemically unmodified collagen mass fixed. 9098 U/005 79098 U / 005 7 BAD ORiGINALBAD ORiGINAL
DE1491218A 1963-06-15 1963-12-12 Blood vessel prosthesis and method for making the same Expired DE1491218C3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS564463 1963-06-15

Publications (3)

Publication Number Publication Date
DE1491218A1 true DE1491218A1 (en) 1969-04-03
DE1491218B2 DE1491218B2 (en) 1972-06-08
DE1491218C3 DE1491218C3 (en) 1973-01-04

Family

ID=5401669

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1491218A Expired DE1491218C3 (en) 1963-06-15 1963-12-12 Blood vessel prosthesis and method for making the same

Country Status (6)

Country Link
US (1) US3425418A (en)
BE (1) BE649183A (en)
BR (1) BR6355428D0 (en)
CH (1) CH472219A (en)
DE (1) DE1491218C3 (en)
GB (1) GB1018288A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416028A (en) * 1981-01-22 1983-11-22 Ingvar Eriksson Blood vessel prosthesis
FR2558720A1 (en) * 1984-01-30 1985-08-02 Meadox Medicals Inc SYNTHETIC VASCULAR GRAFT, PROCESS FOR PREPARING SUCH A DISTRIBUTION GRAFT OF A MEDICAMENT COATED WITH COLLAGEN AND THINNING FOR FORMING THE SAME
EP0183365A2 (en) * 1984-11-30 1986-06-04 Vascutek Limited Vascular graft
EP0230635A2 (en) * 1985-12-24 1987-08-05 Sumitomo Electric Industries Limited Tubular prosthesis having a composite structure
EP0237037A2 (en) * 1986-03-12 1987-09-16 B. Braun Medical AG Vascular prosthesis impregnated with cross-linked gelatin and method of making the same
US5716660A (en) * 1994-08-12 1998-02-10 Meadox Medicals, Inc. Tubular polytetrafluoroethylene implantable prostheses
US5851230A (en) * 1994-08-12 1998-12-22 Meadox Medicals, Inc. Vascular graft with a heparin-containing collagen sealant
US5986168A (en) * 1995-04-25 1999-11-16 Nicem, Ltd. Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making the same
US6129757A (en) * 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
WO2011012178A2 (en) 2009-07-31 2011-02-03 Aesculap Ag. Tubular implant for replacing natural blood vessels

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526005A (en) * 1967-06-29 1970-09-01 Gulf General Atomic Inc Method of preparing an intravascular defect by implanting a pyrolytic carbon coated prosthesis
US3688317A (en) * 1970-08-25 1972-09-05 Sutures Inc Vascular prosthetic
US3710777A (en) * 1970-12-23 1973-01-16 C Sparks Method and apparatus for growing graft tubes in place
US3710400A (en) * 1971-08-30 1973-01-16 C Sparks Graft member grown in a living body
US3908657A (en) * 1973-01-15 1975-09-30 Univ Johns Hopkins System for continuous withdrawal of blood
US3974526A (en) * 1973-07-06 1976-08-17 Dardik Irving I Vascular prostheses and process for producing the same
US6436135B1 (en) 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
US4101984A (en) * 1975-05-09 1978-07-25 Macgregor David C Cardiovascular prosthetic devices and implants with porous systems
US4280954A (en) 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
GB1515963A (en) * 1975-07-15 1978-06-28 Massachusetts Inst Technology Crosslinked collagen-mucopolysaccharide composite materials
JPS5413694A (en) * 1977-07-01 1979-02-01 Sumitomo Electric Industries Composite blood vessel prosthesis and method of producing same
DE2853614A1 (en) * 1978-01-25 1979-07-26 Bentley Lab IMPLANT
AU516741B2 (en) * 1978-05-23 1981-06-18 Bio Nova Neo Technics Pty. Ltd. Vascular prostheses
JPS6037735B2 (en) * 1978-10-18 1985-08-28 住友電気工業株式会社 Artificial blood vessel
SE424401B (en) * 1979-06-06 1982-07-19 Bowald S BLODKERLSPROTES
US4539716A (en) * 1981-03-19 1985-09-10 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
US4546500A (en) * 1981-05-08 1985-10-15 Massachusetts Institute Of Technology Fabrication of living blood vessels and glandular tissues
ATE13477T1 (en) * 1981-07-02 1985-06-15 Intermedicat Gmbh PROCESS FOR THE PRODUCTION OF SCLEROPROTEIN TRANSPLANTS WITH INCREASED BIOLOGICAL STABILITY.
IT1154510B (en) * 1981-08-14 1987-01-21 Bentley Lab CONNECTOR DEVICE IMPLANTABLE IN THE BODY AND DEVICE OF VASCULAR IMPLANTATION ASSOCIATED WITH IT
US4442133A (en) * 1982-02-22 1984-04-10 Greco Ralph S Antibiotic bonding of vascular prostheses and other implants
US5110852A (en) * 1982-07-16 1992-05-05 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
NL8202894A (en) * 1982-07-16 1984-02-16 Rijksuniversiteit POLYESTER FILAMENT MATERIAL.
JPH0631316B2 (en) * 1982-08-04 1994-04-27 ラ ジヨラ キヤンサ− リサ−チ フアンデイシヨン Polypeptide
US4695281A (en) * 1983-03-25 1987-09-22 Koken Co., Ltd. Medical material
EP0128501B1 (en) * 1983-06-06 1989-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Artificial vessel and process for preparing the same
US4670286A (en) * 1983-09-20 1987-06-02 Allied Corporation Method of forming prosthetic devices
FR2556210B1 (en) * 1983-12-08 1988-04-15 Barra Jean Aubert VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME
DE3546875C2 (en) * 1984-01-30 1996-05-09 Meadox Medicals Inc Synthetic vascular grafts
IL74179A (en) * 1984-01-30 1992-05-25 Meadox Medicals Inc Collagen synthetic vascular graft
US4842575A (en) * 1984-01-30 1989-06-27 Meadox Medicals, Inc. Method for forming impregnated synthetic vascular grafts
US5197977A (en) * 1984-01-30 1993-03-30 Meadox Medicals, Inc. Drug delivery collagen-impregnated synthetic vascular graft
US5108424A (en) * 1984-01-30 1992-04-28 Meadox Medicals, Inc. Collagen-impregnated dacron graft
GB2156677A (en) * 1984-03-31 1985-10-16 Wessex Medical Group Ltd Bioprosthetic conduits
DE169259T1 (en) * 1984-07-25 1986-04-30 Surgical Patent Products Inc. Ltd., Panama VESSEL PROSTHESES FOR DRY STORAGE, METHOD FOR TREATMENT AND THEIR USE IN SURGERY.
US5037377A (en) * 1984-11-28 1991-08-06 Medtronic, Inc. Means for improving biocompatibility of implants, particularly of vascular grafts
US4744792A (en) * 1985-01-22 1988-05-17 Richards Medical Company Middle ear ventilating tube
US4629458A (en) * 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
US4997440A (en) * 1985-04-25 1991-03-05 American Cyanamid Company Vascular graft with absorbable and nonabsorbable components
GB8516421D0 (en) * 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
EP0323144A3 (en) * 1987-12-28 1990-05-16 Vyzkumny Ustav Potravinarskeho Prumyslu Method of manufacturing at least single-layer tubular blood vessel endoprosthesis, especially of a small internal diameter, and extruding nozzle for carrying out this method
US5192311A (en) * 1988-04-25 1993-03-09 Angeion Corporation Medical implant and method of making
US4927410A (en) * 1988-11-18 1990-05-22 University Of South Florida Method for fabricating prosthesis material
US5256418A (en) * 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
CS277367B6 (en) * 1990-12-29 1993-01-13 Krajicek Milan Three-layered vascular prosthesis
US5383927A (en) * 1992-05-07 1995-01-24 Intervascular Inc. Non-thromogenic vascular prosthesis
US20020055710A1 (en) * 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
EP0858298A4 (en) * 1994-04-29 1999-04-07 Boston Scient Corp Medical prosthetic stent and method of manufacture
EP0754017B1 (en) 1994-04-29 2002-06-19 SciMed Life Systems, Inc. Stent with collagen
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US6177609B1 (en) 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
US7241309B2 (en) * 1999-04-15 2007-07-10 Scimed Life Systems, Inc. Self-aggregating protein compositions and use as sealants
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6203536B1 (en) * 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US6013099A (en) * 1998-04-29 2000-01-11 Medtronic, Inc. Medical device for delivering a water-insoluble therapeutic salt or substance
US20070031607A1 (en) * 2000-12-19 2007-02-08 Alexander Dubson Method and apparatus for coating medical implants
US20020084178A1 (en) * 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US20040030377A1 (en) * 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
EP1377419A4 (en) * 2001-03-20 2004-05-26 Nicast Ltd Method and apparatus of improving mechanical characteristics of nonwoven materials
WO2005065578A2 (en) * 2004-01-06 2005-07-21 Nicast Ltd. Vascular prosthesis with anastomotic member
US7794490B2 (en) * 2004-06-22 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices with antimicrobial and biodegradable matrices
US8029563B2 (en) * 2004-11-29 2011-10-04 Gore Enterprise Holdings, Inc. Implantable devices with reduced needle puncture site leakage
WO2006087721A2 (en) * 2005-02-17 2006-08-24 Nicast Ltd. Inflatable medical device
CA2906621A1 (en) 2013-03-15 2014-09-25 Baxter International Inc. Immobilization of active agent on a substrate
US9655917B2 (en) 2013-06-07 2017-05-23 Baxter International Inc. Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups
US9814560B2 (en) 2013-12-05 2017-11-14 W. L. Gore & Associates, Inc. Tapered implantable device and methods for making such devices
CN104027844A (en) * 2014-04-04 2014-09-10 张志辉 Novel method for coating artificial blood vessel with Astragalus polysaccharide
CN107666882B (en) 2015-06-05 2020-01-10 W.L.戈尔及同仁股份有限公司 Hypotonic blood volume implantable prosthesis with tapered portion
WO2018007849A1 (en) 2016-07-05 2018-01-11 Carlos Alvarado Serous membrane for ocular surface disorders
CZ308556B6 (en) * 2017-07-26 2020-11-25 Vseobecna Fakultni Nemocnice V Praze Composite vascular replacement and manufacturing method
US11801630B2 (en) 2017-07-28 2023-10-31 Stratasys Ltd. Method and system for fabricating object featuring properties of a blood vessel
ES2967291T3 (en) 2017-07-28 2024-04-29 Stratasys Ltd Additive manufacturing processes that use a material that has properties of a soft body tissue
US11549012B2 (en) 2017-07-28 2023-01-10 Stratasys Ltd. Formulations usable in additive manufacturing of a three-dimensional object made of a soft material
EP3658359B1 (en) 2017-07-28 2023-11-15 Stratasys Ltd. Method and system for fabricating object featuring properties of a hard tissue
CN110141681B (en) * 2019-05-24 2021-09-10 深圳齐康医疗器械有限公司 Wound repair material for cell suspension transplantation and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB591509A (en) * 1945-03-26 1947-08-20 Raymond Nigel Roy A soluble lumen suture support
US3106483A (en) * 1961-07-27 1963-10-08 Us Catheter & Instr Corp Synthetic blood vessel grafts
US3108357A (en) * 1962-06-20 1963-10-29 William J Liebig Compound absorbable prosthetic implants, fabrics and yarns therefor
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416028A (en) * 1981-01-22 1983-11-22 Ingvar Eriksson Blood vessel prosthesis
FR2558720A1 (en) * 1984-01-30 1985-08-02 Meadox Medicals Inc SYNTHETIC VASCULAR GRAFT, PROCESS FOR PREPARING SUCH A DISTRIBUTION GRAFT OF A MEDICAMENT COATED WITH COLLAGEN AND THINNING FOR FORMING THE SAME
EP0183365A2 (en) * 1984-11-30 1986-06-04 Vascutek Limited Vascular graft
EP0183365A3 (en) * 1984-11-30 1988-04-06 J. & P. Coats, Limited Vascular graft
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
EP0230635A2 (en) * 1985-12-24 1987-08-05 Sumitomo Electric Industries Limited Tubular prosthesis having a composite structure
EP0230635A3 (en) * 1985-12-24 1988-04-06 Sumitomo Electric Industries Limited Tubular prosthesis having a composite structure
EP0237037A2 (en) * 1986-03-12 1987-09-16 B. Braun Medical AG Vascular prosthesis impregnated with cross-linked gelatin and method of making the same
EP0237037A3 (en) * 1986-03-12 1988-04-06 Intermedicat Gmbh Vascular prosthesis impregnated with cross-linked gelatin and method of making the same
US5716660A (en) * 1994-08-12 1998-02-10 Meadox Medicals, Inc. Tubular polytetrafluoroethylene implantable prostheses
US5851230A (en) * 1994-08-12 1998-12-22 Meadox Medicals, Inc. Vascular graft with a heparin-containing collagen sealant
US6162247A (en) * 1994-08-12 2000-12-19 Meadox Medicals, Inc. Vascular graft impregnated with a heparin-containing collagen sealant
US5986168A (en) * 1995-04-25 1999-11-16 Nicem, Ltd. Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making the same
US6129757A (en) * 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
US6210436B1 (en) 1998-05-18 2001-04-03 Scimed Life Systems Inc. Implantable members for receiving therapeutically useful compositions
US6447542B1 (en) 1998-05-18 2002-09-10 Scimed Life Systems, Inc. Implantable members for receiving therapeutically useful compositions
WO2011012178A2 (en) 2009-07-31 2011-02-03 Aesculap Ag. Tubular implant for replacing natural blood vessels

Also Published As

Publication number Publication date
US3425418A (en) 1969-02-04
DE1491218B2 (en) 1972-06-08
GB1018288A (en) 1966-01-26
CH472219A (en) 1969-05-15
BE649183A (en) 1964-10-01
BR6355428D0 (en) 1973-07-19
DE1491218C3 (en) 1973-01-04

Similar Documents

Publication Publication Date Title
DE1491218A1 (en) Highly porous collagen tissue blood vessel prosthesis and method for producing the same
EP1948260B8 (en) Composite material, especially for medical use, and method for producing the same
DE60018814T2 (en) Sewable membrane for adhesion prevention
EP2926840B1 (en) Method for the treatment of biological tissue for dry use in an implant
DE69122369T2 (en) Three-layer vascular prosthesis
DE69720769T2 (en) ARTIFICIAL NEURAL CHANNEL
EP0248247B1 (en) Vascular graft wall
DE69525692T2 (en) Implantable tubular prosthesis made of polytetrafluoroethylene
DE602004000323T2 (en) Preparations for the restoration and regeneration of human dura mater
DE69425358T2 (en) USE OF A POROUS CALCIUM CARBONATE MATERIAL AS A SUPPORT FOR A GROWTH FACTOR IN THE PRODUCTION OF A RESORBABLE IMPLANT
EP1948263B1 (en) Nerve guide
DE60212311T2 (en) Adhesion preventing membranes, methods of making a collagen single strand, method and apparatus for making a collagen web
DE10135275A1 (en) Implant and process for its manufacture
DE102009060623B4 (en) Artificial bone that is absorbable and replaceable by autogenous bone, as well as its manufacturing process
DE102004024635A1 (en) Process for the preparation of moldings based on crosslinked gelatin
EP3165239B1 (en) Method for reducing paravalvular leaks with decellularized tissue
DE69429894T2 (en) Use of a surgical composite
DE102009057545A1 (en) Artificial bone that is absorbable and replaceable by autogenous bone, as well as its manufacturing process
DE102005054938A1 (en) Shaped body based on a crosslinked, gelatin-containing material, process for their preparation and their use
DE69327793T2 (en) ABSORBABLE TOPICAL BLOODSTILL
DE3913926C2 (en)
EP1957125B1 (en) Method for producing a hollow profile using a cross-linked, gelatinous material and implants in the form of hollow profiles
AT241016B (en) Highly porous collagen tissue blood vessel prosthesis and method for making the same
DE102005054937A1 (en) Angiogenesis promoting substrate
DE102006042631A1 (en) Implant and method for its production

Legal Events

Date Code Title Description
SH Request for examination between 03.10.1968 and 22.04.1971
C3 Grant after two publication steps (3rd publication)